R Heyne

1.4k total citations
59 papers, 673 citations indexed

About

R Heyne is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, R Heyne has authored 59 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hepatology, 46 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in R Heyne's work include Hepatitis C virus research (48 papers), Liver Disease Diagnosis and Treatment (32 papers) and Hepatitis B Virus Studies (30 papers). R Heyne is often cited by papers focused on Hepatitis C virus research (48 papers), Liver Disease Diagnosis and Treatment (32 papers) and Hepatitis B Virus Studies (30 papers). R Heyne collaborates with scholars based in Germany, United States and Estonia. R Heyne's co-authors include Thomas Berg, Stefan Mauss, Eckart Schott, Christoph Eisenbach, Markus Cornberg, G Felten, Jörg Petersen, Karl‐Georg Simon, Tobias Warger and L Gallo and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

R Heyne

52 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R Heyne Germany	15	586	552	63	45	41	59	673
Alain Cazier France	10	307 0.5×	323 0.6×	35 0.6×	34 0.8×	67 1.6×	21	544
Riina Salupere Estonia	6	561 1.0×	593 1.1×	112 1.8×	17 0.4×	44 1.1×	12	706
V. Carreño Spain	14	468 0.8×	514 0.9×	81 1.3×	25 0.6×	25 0.6×	32	710
Julia O’Brien United Kingdom	9	400 0.7×	399 0.7×	74 1.2×	10 0.2×	49 1.2×	12	510
C. Vandelli Italy	10	513 0.9×	525 1.0×	92 1.5×	27 0.6×	46 1.1×	26	674
Khanh K. Nguyen United States	15	664 1.1×	606 1.1×	64 1.0×	12 0.3×	55 1.3×	44	765
Denis Vetter France	10	437 0.7×	553 1.0×	52 0.8×	15 0.3×	104 2.5×	11	678
Li‐Po Lee Taiwan	18	1.0k 1.7×	1.1k 1.9×	49 0.8×	29 0.6×	36 0.9×	29	1.2k
Enrique L. Álvarez Spain	11	218 0.4×	217 0.4×	65 1.0×	12 0.3×	57 1.4×	29	403
Teresa Aldámiz‐Echevarría Spain	13	277 0.5×	223 0.4×	125 2.0×	22 0.5×	22 0.5×	47	483

Countries citing papers authored by R Heyne

Since Specialization

Citations

This map shows the geographic impact of R Heyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Heyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Heyne more than expected).

Fields of papers citing papers by R Heyne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Heyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Heyne. The network helps show where R Heyne may publish in the future.

Co-authorship network of co-authors of R Heyne

This figure shows the co-authorship network connecting the top 25 collaborators of R Heyne. A scholar is included among the top collaborators of R Heyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Heyne. R Heyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fischer, Janett, Tobias Müller, R Heyne, et al.. (2023). Sex‐differences in the association of interleukin‐10 and interleukin‐12 variants with the progression of hepatitis B virus infection in Caucasians. Hepatology Research. 53(12). 1156–1168.

Fischer, Janett, Tobias Müller, R Heyne, et al.. (2022). Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens. 12(1). 54–54. 5 indexed citations

Petersen, Jörg, Wolf Peter Hofmann, Holger Hinrichsen, et al.. (2021). Real-World Clinical Management of Patients with Primary Biliary Cholangitis—A Retrospective Multicenter Study from Germany. Journal of Clinical Medicine. 10(5). 1061–1061. 13 indexed citations

Petroff, David, Olaf Bätz, Jan Kramer, et al.. (2021). From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology Practice. Pathogens. 10(12). 1570–1570. 4 indexed citations

Pfefferkorn, Maria, Stephan Böhm, Danilo Deichsel, et al.. (2020). Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B. Journal of Hepatology. 74(2). 283–292. 43 indexed citations

Hofmann, Wolf Peter, Peter Buggisch, Lisa Schubert, et al.. (2020). The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. JHEP Reports. 2(6). 100168–100168. 14 indexed citations

Stoehr, Albrecht, Hartwig Klinker, G Teuber, et al.. (2020). Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease - Data from the German Hepatitis C-Registry (DHC-R). Zeitschrift für Gastroenterologie. 2 indexed citations

Christensen, Steen Bach, Albrecht Stoehr, Markus Cornberg, et al.. (2019). High real-world effectiveness of elbasvir/grazoprevir (EBR/GZR) in PWID on opioid substitution therapy with HCV genotype 1 (GT1) infection: results from the German Hepatitis C Registry (DHC-R). Zeitschrift für Gastroenterologie. 1 indexed citations

Stahmeyer, Jona T., S. Rossol, Klaus H.W. Böker, et al.. (2016). Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors – Results from the PAN Study. PLoS ONE. 11(7). e0159976–e0159976. 7 indexed citations

10.

Zoulim, Fabien, Jolanta Białkowska, Mircea Diculescu, et al.. (2016). Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure. Hepatology International. 10(5). 779–788. 16 indexed citations

11.

Petersen, Jörg, R Heyne, Stefan Mauss, et al.. (2015). Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany. Digestive Diseases and Sciences. 61(10). 3061–3071. 34 indexed citations

12.

Petersen, J., R Heyne, JF Schlaak, et al.. (2014). O122 EFFECTIVENESS OF TENOFOVIR DF FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 3 YEAR FINAL RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY. Journal of Hepatology. 60(1). S51–S51. 3 indexed citations

13.

Petersen, John Asger, R Heyne, JF Schlaak, et al.. (2013). 768 EFFECTIVENESS OF TENOFOVIR FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 2 YEAR INTERIM RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY (GEMINIS). Journal of Hepatology. 58. S313–S313. 5 indexed citations

14.

Stahmeyer, Jona T., S. Rossol, Ahmed Abdelfattah, et al.. (2013). Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial. Value in Health. 16(7). A341–A342. 2 indexed citations

15.

Mauss, Stefan, Klaus H.W. Böker, Thomas A. Lutz, et al.. (2013). Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice. European Journal of Gastroenterology & Hepatology. 26(1). 65–73. 3 indexed citations

16.

Möller, Bernd, R Heyne, Adam Herber, et al.. (2012). Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection. European Journal of Gastroenterology & Hepatology. 25(4). 416–420. 11 indexed citations

17.

Hueppe, D., C John, R Heyne, et al.. (2010). Estimating the likelihood of sustained virological response in chronic hepatitis C therapy. Journal of Viral Hepatitis. 18(4). e81–90. 19 indexed citations

18.

Witthoeft, T., D. Hueppe, C John, et al.. (2010). Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study. Journal of Viral Hepatitis. 17(7). 459–68. 23 indexed citations

19.

Jaeckel, Elmar, E Zehnter, C John, et al.. (2010). 266 CLINICAL MARKERS OF THE METABOLIC SYNDROME ARE ASSOCIATED WITH HCV GENOTYPE 1 INFECTION AND ARE STRONG NEGATIVE PREDICTORS OF EARLY VIROLOGICAL RESPONSE. Journal of Hepatology. 52. S112–S112. 2 indexed citations

20.

Heyne, R, S Rickes, P.R. Bock, et al.. (2002). Non-invasive Evaluation of Activity in Inflammatory Bowel Disease by Power Doppler Sonography*. Zeitschrift für Gastroenterologie. 40(3). 171–175. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact